|
CLPTM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.097600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.504200E-01 |
| Normal-vs-Stage2 |
2.558300E-03 |
| Normal-vs-Stage3 |
2.536200E-01 |
| Normal-vs-Stage4 |
6.608400E-01 |
| Stage1-vs-Stage2 |
1.195550E-02 |
| Stage1-vs-Stage3 |
1.247580E-02 |
| Stage1-vs-Stage4 |
1.757550E-01 |
| Stage2-vs-Stage3 |
1.228840E-04 |
| Stage2-vs-Stage4 |
2.843300E-03 |
| Stage3-vs-Stage4 |
6.226400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.628200E-01 |
| Normal-vs-AfricanAmerican |
2.441000E-01 |
| Normal-vs-Asian |
7.122400E-02 |
| Caucasian-vs-AfricanAmerican |
2.413200E-01 |
| Caucasian-vs-Asian |
8.144000E-02 |
| AfricanAmerican-vs-Asian |
9.138800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.389800E-01 |
| Normal-vs-Female |
4.116600E-01 |
| Male-vs-Female |
9.315600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.615400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.327600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.522600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.677600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.498000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.880800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.646200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.427600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.721400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.948800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.28789999775947E-08 |
| Classical-VS-Follicular |
2.922100E-02 |
| Classical-VS-Other |
3.442000E-01 |
| Classical-VS-Normal |
3.518600E-01 |
| Tall-VS-Follicular |
6.87010004440936E-10 |
| Tall-VS-Other |
7.221500E-02 |
| Tall-VS-Normal |
2.33909999999282E-05 |
| Follicular-VS-Other |
1.330030E-01 |
| Follicular-VS-Normal |
1.559800E-02 |
| Other-VS-Normal |
3.860800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.328100E-02 |
| Normal-vs-N1 |
8.211600E-02 |
| N0-vs-N1 |
2.200300E-04 |
|
|
